Florida Pharmaceutical Products, LLC (FPP,) a pharmaceutical company involved in the development, sales, marketing and distribution of generic pharmaceuticals, and Ayrton Saunders Ltd. (ASL) a company involved in the development and licensing of pharmaceuticals, have signed an agreement for the licensing of an ANDA developed by ASL’s affiliate company Impopharma Canada Limited, currently filed with the FDA and expected to be approved mid-2020.   The product has sales of approximately $70 million...